Related references
Note: Only part of the references are listed.24-Month Use of Once-Weekly GH, LB03002, in Prepubertal Children With GH Deficiency
Vaman Khadilkar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Endocrine Control of Growth
Philip G. Murray et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2013)
Three-Year Efficacy and Safety of LB03002, a Once-Weekly Sustained-Release Growth Hormone (GH) Preparation, in Prepubertal Children with GH Deficiency (GHD)
Ferenc Peter et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Long-acting pegylated human GH in children with GH deficiency: a single-dose, dose-escalation trial investigating safety, tolerability, pharmacokinetics and pharmacodynamics
Jean de Schepper et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
The effect of different patterns of growth hormone administration on the IGF axis and somatic and skeletal growth of the dwarf rat
Melissa Westwood et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient children
SF Kemp et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Short-term growth in children with growth disorders
V Tillmann et al.
ANNALS OF HUMAN BIOLOGY (2002)
Short-term changes in growth and urinary growth hormone, insulin-like growth factor-I and markers of bone turnover excretion in healthy prepubertal children
V Tillmann et al.
GROWTH HORMONE & IGF RESEARCH (2000)